Related Experiment Videos
Coronary angioplasty in acute myocardial infarction: primary, immediate adjunctive, rescue, or deferred adjunctive
R D Simari1, P B Berger, M R Bell
1Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic Rochester, Minnesota 55905.
Insights
Primary angioplasty is effective for acute myocardial infarction, especially when thrombolytic therapy is contraindicated. Rescue angioplasty may help failed thrombolysis, but immediate or deferred angioplasty offers no clear benefits.
Area of Science:
- Cardiology
- Interventional Cardiology
- Acute Myocardial Infarction Management
Background:
- Coronary angioplasty is a key intervention for acute myocardial infarction.
- Thrombolytic therapy has been the standard treatment, but its efficacy is debated.
- Optimizing reperfusion strategies is crucial for improving patient outcomes.
Purpose of the Study:
- To evaluate the clinical applications, outcomes, and limitations of coronary angioplasty in acute myocardial infarction.
- To compare different angioplasty strategies (primary, adjunctive, rescue, deferred) with thrombolysis.
- To identify optimal timing and use of angioplasty in conjunction with thrombolytic therapy.
Main Methods:
- Review of results from large clinical trials comparing thrombolysis with various coronary angioplasty strategies.
- Analysis of meta-analyses examining survival and reinfarction rates.
- Assessment of randomized trials evaluating immediate, rescue, and deferred angioplasty.
Main Results:
- Primary angioplasty is as effective as thrombolysis for myocardial salvage and may improve survival and reduce reinfarction.
- Immediate adjunctive angioplasty after thrombolysis shows no survival or functional benefits and increases risks.
- Rescue angioplasty may be beneficial for failed thrombolysis; deferred angioplasty does not reduce mortality or reinfarction.
Conclusions:
- Primary coronary angioplasty is the preferred treatment for patients unable to receive thrombolytic therapy.
- High-risk subgroups may benefit from primary angioplasty.
- Further trials are needed to clarify the role of rescue angioplasty.
Objective:
To address the current clinical applications, outcomes, and limitations of coronary angioplasty in the setting of acute myocardial infarction.
Design:
We review the results of several large trials in which various strategies of thrombolysis and primary, immediate adjunctive, rescue, or deferred adjunctive coronary angioplasty were used in patients with acute myocardial infarction.
Material And Methods:
Four strategies for the utilization of angioplasty in myocardial infarction have been developed and are based on the timing and concurrent use of thrombolytic therapy.
Results:
Primary coronary angioplasty without prior thrombolytic therapy is as effective as thrombolytic therapy for salvaging myocardium. Results of a meta-analysis of recent trials suggest potential benefits of increased survival and decreased reinfarction in comparison with the results of thrombolysis in recent trials. Immediate adjunctive angioplasty after thrombolytic therapy has been tested in three large, randomized trials. The results suggest that this strategy is associated with increased risks without benefits of increased survival or improved left ventricular function. Rescue angioplasty may be helpful after failed thrombolytic therapy. Ongoing randomized trials might further clarify the benefits of rescue angioplasty. Because of the inherent difficulty in the noninvasive identification of patients with persistent reocclusion, diagnostic coronary angiography early after thrombolytic therapy may be necessary. Deferred adjunctive angioplasty during the weeks after infarction to prevent recurrent ischemia was not shown to decrease mortality or reinfarction in two large trials.
Conclusion:
Primary coronary angioplasty is the treatment of choice for patients with contraindications to thrombolytic therapy. Certain high-risk subgroups may also benefit from primary angioplasty.